Accordingly, IL-33-deficient mice developed a dysregulated gut microbiota (Malik et al., 2016), and altered gut microbiota in IL-1α-knockout mice resulted in protection against DSS-induced colitis (Nunberg et al., 2018). The gene discussed is IL33; the disease is colitis.